CN106496620A - A kind of modified collagen and preparation method thereof - Google Patents

A kind of modified collagen and preparation method thereof Download PDF

Info

Publication number
CN106496620A
CN106496620A CN201611025503.XA CN201611025503A CN106496620A CN 106496620 A CN106496620 A CN 106496620A CN 201611025503 A CN201611025503 A CN 201611025503A CN 106496620 A CN106496620 A CN 106496620A
Authority
CN
China
Prior art keywords
collagen
modified collagen
preparation
tea polyphenols
collagem
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201611025503.XA
Other languages
Chinese (zh)
Inventor
屈依丽
朱宸佑
向琳
邓佳
伍颖颖
刘丽
满毅
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sichuan University
Original Assignee
Sichuan University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sichuan University filed Critical Sichuan University
Priority to CN201611025503.XA priority Critical patent/CN106496620A/en
Publication of CN106496620A publication Critical patent/CN106496620A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08JWORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J7/00Chemical treatment or coating of shaped articles made of macromolecular substances
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14Macromolecular materials
    • A61L27/22Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/24Collagen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54Biologically active materials, e.g. therapeutic substances
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08JWORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J3/00Processes of treating or compounding macromolecular substances
    • C08J3/24Crosslinking, e.g. vulcanising, of macromolecules
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08JWORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J5/00Manufacture of articles or shaped materials containing macromolecular substances
    • C08J5/18Manufacture of films or sheets
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08JWORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J7/00Chemical treatment or coating of shaped articles made of macromolecular substances
    • C08J7/12Chemical modification
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08LCOMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L89/00Compositions of proteins; Compositions of derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/216Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials with other specific functional groups, e.g. aldehydes, ketones, phenols, quaternary phosphonium groups
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00Materials or treatment for tissue regeneration
    • A61L2430/02Materials or treatment for tissue regeneration for reconstruction of bones; weight-bearing implants
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08JWORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2389/00Characterised by the use of proteins; Derivatives thereof

Abstract

The invention provides a kind of modified collagen, preparation method is as follows:With culture plate as mould, collagen protein 2ml is taken, it is collagem membrane to be prepared in 10%w/v acetums to add concentration;According to 1000mg:The 300mg collagem membranes of preparation are placed in precrosslink in 0.64%w/v tea polyphenols solution by the ratio of 1ml, are soaked in the 0.05 mol/L acetums containing 0.64%w/v tea polyphenols, crosslinking, and cleaning is obtained final product after drying.It is an advantage of the current invention that:Prepared modified collagen has the aggregation that more preferable ability induces repairing type macrophage, improve the biological property of collagem membrane, the bio-toxicity of medicine collagen composite membrane is reduced, and with good application prospect, new selection is provided for the related increment operation such as guiding regeneration art.

Description

A kind of modified collagen and preparation method thereof
Technical field
The invention belongs to technical field of biological material, and in particular to a kind of modified collagen and preparation method thereof.
Background technology
Often need to apply Guided Bone Regeneration operation to carry out bone increment in dental operation.Collagen be extracellular matrix one kind into Point, have been widely used in guided bone regeneration.Collagem membrane has preferable bio-compatibility, and osteoblast can be promoted to stick Attached, propagation, migration and break up, can also have stop fibroblast quickly invade bone growth site, separate soft tissue with hard The barrier functions such as the growth of tissue.
However, used as a kind of exogenous graft thing, collagen still can cause certain inflammatory reaction, at the same also because it Readily degradable and lack preferable mechanical performance.Commonly used in the art be crosslinked with collagen using glutaraldehyde, so as to improve its Mechanical performance, but easily cause inflammation and produce cytotoxicity.Therefore, the long-term preservation of collagem membrane and use, necessary not only for Mechanical performance is improved, antiinflammatory is more wanted and is improved bio-compatibility.
Tea polyphenols(Catchine)It is a kind of polyphenol from green tea, it has numerous biological functions, extensively receives in recent years Concern.Scientists find that tea polyphenols have anticancer, antioxidation, anti-inflammatory, fibrosis and promote the effect of skeletonization.Meanwhile, As a kind of modifying agent of collagen, Chu et al., it can also report which can both strengthen the mechanical performance of collagen, will not also destroy The triple helix structure of collagen.Therefore, EGCG- collagen composite membranes can be used in the operation such as Guided Bone Regeneration, and have good Prospect.
The report such as Sadtler, effect of the collagen with induction repairing type macrophage, can promote M2 in the recent period(Repairing type Macrophage)The aggregation of cell and the repairing type path of mTOR mediations, and then promote the reparation of muscular tissue.
Tea polyphenols incorporating collagen film is wanted to alleviate due to inflammatory reaction caused by foreign body by the present invention, while inducing repairing type The aggregation of macrophage, and then promotion organization reparation.
Content of the invention
The purpose of the present invention is for the deficiencies in the prior art, there is provided a kind of modified collagen and preparation method thereof.
In order to achieve the above object, following technical proposal present invention employs:A kind of modified collagen, preparation method are as follows:
A, with culture plate as mould, take collagen protein 2ml, it is to prepare collagem membrane in 10%w/v acetums to add concentration;
B, according to 1000mg:The 300mg collagem membranes of preparation are placed in precrosslink in 0.64%w/v tea polyphenols solution by the ratio of 1ml, The 0.05 mol/L acetums containing 0.64%w/v tea polyphenols are soaked in, are crosslinked, cleaning is obtained final product after drying.
Preferably, the collagen protein is Niu Laiyuan type i collagens.
Preferably, in step A, freeze overnight at a temperature of -20 DEG C, under the conditions of -53 DEG C, 1 Pa, vacuum is cold The dry 24h of lyophilizing.
Preferably, in step B, the precrosslink time is 10-60min.
Preferably, in step B, crosslinking time is 24h.
Preferably, in step B, by the tea polyphenols-collagen composite membrane lyophilization under the conditions of -20 DEG C for preparing Overnight.
It is an advantage of the current invention that:It is thin that modified collagen prepared by the present invention has more preferable ability induction repairing type macrophage The aggregation of born of the same parents, improves the biological property of collagem membrane, reduces the bio-toxicity of medicine-collagen composite membrane, answers with good With prospect, new selection is provided for the related increment operation such as guiding regeneration art.
Description of the drawings
Fig. 1 is 3 flow cytometry tests result figure of embodiment.
Fig. 2 is 3 polymerase chain reaction experimental result picture of embodiment.
Fig. 3 is 3 polymerase chain reaction experimental result picture of embodiment.
Fig. 4 is embodiment 3HE Coloration experiment result figure.
Fig. 5 is embodiment 3Masson Coloration experiment result figure.
Specific embodiment
Below in conjunction with the accompanying drawings, the present invention is described in detail.
In order that the objects, technical solutions and advantages of the present invention become more apparent, below in conjunction with drawings and Examples, right The present invention is further elaborated.It should be appreciated that specific embodiment described herein is only in order to explain the present invention, and It is not used in the restriction present invention.
Embodiment 1:As mould, it is 10% in concentration to add collagen protein 2mL to culture plate with a diameter of 3.5cm/ holes(w/ v)Acetum.- 26 DEG C of cryogenic refrigerator freeze overnights, under the conditions of -53 DEG C, 1Pa, prepared by freeze dryer vacuum lyophilization 24h Collagem membrane.
2. tea polyphenols(0.64%)Gradient concentration solution is prepared.
3. the modified collagem membrane of tea polyphenols
The collagem membrane of preparation is placed in 0.64% tea polyphenols after 10 min of precrosslink, 0.05 containing 0.64% tea polyphenols is soaked in Mol/L acetums, are crosslinked 24 h in 4 DEG C, and l X PBSs are rinsed 3 times.
By the collagem membrane for preparing under the conditions of -20 DEG C lyophilized overnight.
Embodiment 2:A kind of modified collagen, preparation method are as follows:
A, with culture plate as mould, take collagen protein 2ml, it is to prepare collagem membrane in 10%w/v acetums to add concentration;
B, according to 1000mg:The 300mg collagem membranes of preparation are placed in precrosslink in 0.64%w/v tea polyphenols solution by the ratio of 1ml, The 0.05 mol/L acetums containing 0.64%w/v tea polyphenols are soaked in, are crosslinked, cleaning is obtained final product after drying.
The collagen protein is Niu Laiyuan type i collagens.
In step A, freeze overnight at a temperature of -20 DEG C, under the conditions of -53 DEG C, 1 Pa, vacuum lyophilization 24h.
In step B, the precrosslink time is 10-60min.
In step B, crosslinking time is 24h.
In step B, by the tea polyphenols-collagen composite membrane for preparing under the conditions of -20 DEG C lyophilized overnight.
Embodiment 3:Bio-compatibility is tested
1. flow cytometry
Male SD rat by 6-8 week old(Weight 250-300g)27 are randomly divided into 9 groups, with 10% chloral hydrate lumbar injection fiber crops After liquor-saturated, in the otch that every rat back makes 3 long 1mm, corresponding material is implanted into(1mm, circular)Afterwards with the nonabsorable of 3-0 Nylon suture sewing-up cut.Mouse is put to death respectively with dislocation of cervical vertebra method the 3rd day, the 5th day, the 7th day, is straight with 1mm otch Footpath ring-type removes full thickness skin tissue, is rinsed with PBS immediately, adds type i collagen enzyme, II Collagenase Types after shredding(0.25mg/ ml)Digestion tissue in the environment of 36.5 degrees Celsius, filters tissue suspension with cell screen clothes after 2 hours, at 1300 turns per minute The lower centrifugation of speed 3 minutes, then rinsed with PBS, add CD206 antibody immediately on ice, after lucifuge incubation half an hour, per minute It is centrifuged 3 minutes under 1300 rotating speeds, add PBS and FITC labellings after removing suspension two resist, after incubation half an hour on ice, It is centrifuged 3 minutes under 1300 rotating speed per minute, after removing suspension, adds PBS, going up machine immediately carries out Flow cytometry.
As shown in figure 1, Flow cytometry material is implanted into the subcutaneous rat CD206 positive(Repairing type macrophage mark Thing)Ratio, as a result point out:Compared to matched group and the group of collagem membrane is applied, the modified collagem membrane of tea polyphenols is significantly lured More repairing type macrophages are led.
2. real-time quantitative polymerase chain reaction (qPCR)
As shown in Fig. 2 material is implanted into rat calvarium Cranial defect(Circle, diameter:5mm)It has been obviously improved CD163, CD206(Repair Type macrophage marker)Expression, and bmp2, runx2, opn, col1a1(Bone formation-related gene).
As shown in figure 3, material is implanted into rat calvarium Cranial defect(Circle, diameter:5mm), relative to collagem membrane group(Col), The modified collagem membrane of tea polyphenols(E-Col)The expression of the growth factor gene for repairing related is obviously promoted, including Ink vessel transfusing Skin growth factor(VEGF), basic fibroblast growth factor (bFGF), platelet derived growth factor (PDGF-A, PDGF-B), Insulin like growth factor(IGF-1), transforming growth factor-β(TGF-β)Expression.
3. HE dyeing
As shown in figure 4, the modified collagem membrane group of tea polyphenols is implanted into rat calvarium Cranial defect(Circle, diameter:5mm), hence it is evident that promote Enter osteanagenesis.
4. Masson dyeing
As shown in figure 5, the modified collagem membrane group of tea polyphenols is obviously promoted the deposition of collagen.
The invention is not limited in aforesaid specific embodiment.The present invention is expanded to and any is disclosed in this manual New feature or any new combination, and the arbitrary new method that discloses or the step of process or any new combination.

Claims (7)

1. a kind of modified collagen, it is characterised in that preparation method is as follows:
A, with culture plate as mould, take collagen protein 2ml, it is to prepare collagem membrane in 10%w/v acetums to add concentration;
B, according to 1000mg:The 300mg collagem membranes of preparation are placed in precrosslink in 0.64%w/v tea polyphenols solution by the ratio of 1ml, The 0.05 mol/L acetums containing 0.64%w/v tea polyphenols are soaked in, are crosslinked, cleaning is obtained final product after drying.
2. a kind of modified collagen according to claim 1, it is characterised in that:The collagen protein is Niu Laiyuan type i collagens.
3. a kind of modified collagen according to claim 1, it is characterised in that:In step A, cold at a temperature of -26 DEG C Freeze overnight, under the conditions of -53 DEG C, 1Pa, vacuum lyophilization 24h.
4. a kind of modified collagen according to claim 1, it is characterised in that:In step B, the precrosslink time is 10- 60min.
5. a kind of modified collagen according to claim 1, it is characterised in that:In step B, crosslinking time is 24h.
6. a kind of modified collagen according to claim 1, it is characterised in that:In step B, will be many for the tea for preparing Phenol-collagen composite membrane lyophilized overnight under the conditions of -20 DEG C.
7. according to a kind of arbitrary described modified collagen of claim 1-6, it is characterised in that:The modified collagen is in medical field Application.
CN201611025503.XA 2016-11-22 2016-11-22 A kind of modified collagen and preparation method thereof Pending CN106496620A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201611025503.XA CN106496620A (en) 2016-11-22 2016-11-22 A kind of modified collagen and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201611025503.XA CN106496620A (en) 2016-11-22 2016-11-22 A kind of modified collagen and preparation method thereof

Publications (1)

Publication Number Publication Date
CN106496620A true CN106496620A (en) 2017-03-15

Family

ID=58327499

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201611025503.XA Pending CN106496620A (en) 2016-11-22 2016-11-22 A kind of modified collagen and preparation method thereof

Country Status (1)

Country Link
CN (1) CN106496620A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108744037A (en) * 2018-06-29 2018-11-06 四川大学 A kind of modified interleukin collagem membrane and its application
CN108853586A (en) * 2018-06-29 2018-11-23 四川大学 A kind of modified tea polyphenol collagem membrane and its application
CN114259602A (en) * 2021-12-29 2022-04-01 江苏江山聚源生物技术有限公司 Recombinant collagen hydrogel for injection and preparation method thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105288734A (en) * 2015-11-23 2016-02-03 四川大学 Composite crosslinked type I collagen membrane and preparation method thereof

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105288734A (en) * 2015-11-23 2016-02-03 四川大学 Composite crosslinked type I collagen membrane and preparation method thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
党美珠: "天然多酚改性鱼鳞胶原蛋白-壳聚糖膜复合材料的制备及其应用研究", 《中国优秀硕士学位论文全文数据库•医药卫生科技辑》 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108744037A (en) * 2018-06-29 2018-11-06 四川大学 A kind of modified interleukin collagem membrane and its application
CN108853586A (en) * 2018-06-29 2018-11-23 四川大学 A kind of modified tea polyphenol collagem membrane and its application
CN114259602A (en) * 2021-12-29 2022-04-01 江苏江山聚源生物技术有限公司 Recombinant collagen hydrogel for injection and preparation method thereof

Similar Documents

Publication Publication Date Title
Qiu et al. Periosteal matrix-derived hydrogel promotes bone repair through an early immune regulation coupled with enhanced angio-and osteogenesis
Pati et al. Biomimetic 3D tissue printing for soft tissue regeneration
Miyagi et al. Biodegradable collagen patch with covalently immobilized VEGF for myocardial repair
Wang et al. Fabrication and characterization of poly (l-lactide-co-glycolide) knitted mesh-reinforced collagen–chitosan hybrid scaffolds for dermal tissue engineering
Guo et al. Enhanced angiogenesis of gene-activated dermal equivalent for treatment of full thickness incisional wounds in a porcine model
Guo et al. The healing of full-thickness burns treated by using plasmid DNA encoding VEGF-165 activated collagen–chitosan dermal equivalents
AU2003231248B2 (en) Vascularization enhanced graft constructs
Ren et al. Fabrication, vascularization and osteogenic properties of a novel synthetic biomimetic induced membrane for the treatment of large bone defects
Quan et al. Gelatin-chondroitin-6-sulfate-hyaluronic acid scaffold seeded with vascular endothelial growth factor 165 modified hair follicle stem cells as a three-dimensional skin substitute
CN105477016A (en) Application of exosome derived from human mesenchymal stem cells to resistance to tissue fibrosis and scar forming
JPH07509638A (en) Production of graft tissue from extracellular matrix
CN108486047B (en) Medical dressing of stem cell extract and preparation method thereof
CN109593124B (en) Umbilical cord mesenchymal stem cell factor freeze-dried powder and preparation method thereof
CN106496620A (en) A kind of modified collagen and preparation method thereof
CN109112110A (en) A kind of mescenchymal stem cell excretion body of load target miRNA, dressing of application and preparation method thereof
Sadeghinia et al. Nano-hydroxy apatite/chitosan/gelatin scaffolds enriched by a combination of platelet-rich plasma and fibrin glue enhance proliferation and differentiation of seeded human dental pulp stem cells
Kim et al. Tissue-engineered esophagus via bioreactor cultivation for circumferential esophageal reconstruction
CN108478863A (en) The preparation method and products thereof of compound small-caliber artificial blood vessel
CN110624097A (en) Application of pearl oyster small molecular peptide in skin wound repair
Shandalov et al. A method for constructing vascularized muscle flap
Tian et al. Repair of urethral defects by an adipose mesenchymal stem cell‑porous silk fibroin material
CN102172337B (en) Tissue engineering skin with sebaceous gland-like structure and preparation method thereof
US20070280959A1 (en) Use Of Platelets Or Platelet Rich Plasma(Prp)
Allbritton‐King et al. Incorporating a structural extracellular matrix gradient into a porcine urinary bladder matrix‐based hydrogel dermal scaffold
CN108066750A (en) Stem cell and its secretion are used to treat the new application of skin burn

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20170315

RJ01 Rejection of invention patent application after publication